Osteopontin is increased in cystic fibrosis and can skew the functional balance between ELR-positive and ELR-negative CXC-chemokines

Journal of Cystic Fibrosis

Volumn 14, Issue 4, 2015, Pages 453-463

  Jovic, Sandra ^a   Shikhagaie, Medya ^a   Mörgelin, Matthias ^a   Erjefält, Jonas S ^a   Kjellström, Sven ^b   Egesten, Arne ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Chemokines; Cystic fibrosis; Host defense; Neutrophils; Osteopontin

Indexed keywords

ALPHA CHEMOKINE; ELASTASE; OSTEOPONTIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NEUTROPHIL; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; CASE CONTROL STUDY; LUNG; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY; SPUTUM;

CASE-CONTROL STUDIES; CHEMOKINES, CXC; CYSTIC FIBROSIS; HUMANS; LUNG; NEUTROPHIL INFILTRATION; OSTEOPONTIN; SPUTUM;

EID: 84937631259     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2014.11.010     Document Type: Article

References (30)

1. O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet 2009, 373:1891-1904.
2. Borregaard N. Neutrophils, from marrow to microbes. Immunity 2010, 33:657-670.
3. Oldberg A., Franzén A., Heinegård D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci 1986, 83:8819-8823.
4. Buback F., Renkl A.C., Schulz G., Weiss J.M. Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology. Exp Dermatol 2009, 18:750-759.
5. Morimoto J., Kon S., Matsui Y., Uede T. Osteopontin; as a target molecule for the treatment of inflammatory diseases. Curr Drug Targets 2010, 11:494-505.
6. El-Tanani M.K., Campbell F.C., Kurisetty V., Jin D., McCann M., Rudland P.S. The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev 2006, 17:463-474.
7. Apte U.M., Banerjee A., McRee R., Wellberg E., Ramaiah S.K. Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis. Toxicol Appl Pharmacol 2005, 207:25-38.
8. Banerjee A., Apte U.M., Smith R., Ramaiah S.K. Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease. J Pathol 2006, 208:473-485.
9. Xu G., Nie H., Li N., et al. Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 2005, 115:1060-1067.
10. Hartl D., Gaggar A., Bruscia E., et al. Innate immunity in cystic fibrosis lung disease. J Cyst Fibros 2012, 11:363-382.
11. Murdoch Craig, Finn Adam Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000, 95:3032-3043.
12. Hartl D., Griese M., Kappler M., Zissel G., et al. Pulmonary t(h)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J Allergy Clin Immunol 2006, 117:204-211.
13. Cole A.M1., Ganz T., Liese A.M., Burdick M.D., Liu L., Strieter R.M. Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J Immunol 2001, 167:623-627.
14. Egesten A., Olin A.I., Linge H.M., et al. SpeB of Streptococcus pyogenes differentially modulates antibacterial and receptor activating properties of human chemokines. PLoS One 2009, 4:e4769.
15. Jovic S., Shikhagaie M., Mörgelin M., et al. Expression of MIG/CXCL9 in cystic fibrosis and modulation of its activities by elastase of Pseudomonas aeruginosa. J Innate Immun 2014, 6:846-859.
16. Yakovleva M., Killyeni A., Seubert O., et al. Further insights into the catalytical properties of deglycosylated pyranose dehydrogenase from Agaricus meleagris recombinantly expressed in Pichia pastoris. Anal Chem 2013, 85:9852-9858.
17. Erdjument-Bromage H., Lui M., Sabatini D.M., Snyder S.H., Tempst P. High-sensitivity sequencing of large proteins. Protein Sci 1994, 3:2435-2446.
18. Arjomandi M., Frelinger J., Donde A., Wong H., Yellamilli A., Raymond W. Secreted osteopontin is highly polymerized in human airways and fragmented in asthmatic airway secretions. PLoS One 2011, 6:e25678.
19. Nishimichi N., Hayashita-Kinoh H., Chen C., Matsuda H., Sheppard D., Yokosaki Y. Osteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1. J Biol Chem 2011, 286:11170-11178.
20. Serlin D.M., Kuang P.P., Subramanian M., O'Regan A., Bergman J.S., Goldstein R.H. Interleukin-1beta induces osteopontin expression in pulmonary fibroblasts. J Cell Biochem 2006, 97:519-529.
21. Sodhi C.P., Phadke S.A., Batlle D., Sahai A. Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. Diabetes 2001, 50:1482-1490.
22. Harris W.T., Muhlebach M.S., Oster R.A., Knowles M.R., Noah T.L. Transforming growth factor-beta(1) in bronchoalveolar lavage fluid from children with cystic fibrosis. Pediatr Pulmonol 2009, 44:1057-1064.
23. Bonfield T.L., Konstan M.W., Burfeind P., Panuska J.R, Hilliard J.B., Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995, 13:257-261.
24. Samitas K., Zervas E., Vittorakis S., et al. Osteopontin expression and relation to disease severity in human asthma. Eur Respir J 2010, 37:331-341.
25. Papaporfyriou A., Loukides S., Kostikas K., et al. Increased levels of osteopontin in sputum supernatant in COPD patients. Chest 2014, 10.1378/chest. 13-2440.
26. Simoes D.C., Xanthou G., Petrochilou K., Panoutsakopoulou V., Roussos C., Gratziou C. Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma. Am J Respir Crit Care Med 2009, 179:894-902.
27. Van der Windt G.J., Hoogerwerf J.J., de Vos A.F., Florquin S., van der Poll T. Osteopontin promotes host defense during Klebsiella pneumoniae-induced pneumonia. Eur Respir J 2010, 36:1337-1345.
28. Van der Windt G.J., Hoogendijk A.J., Schouten M., et al. Osteopontin impairs host defense during the unique role of natural killer t cells in the response to microorganisms. Nat Rev Microbiol J Infect Dis 2011, 203:1850-1858.
29. Koh A., Da Silva A.P., Bansal A.K., et al. Role of osteopontin in neutrophil function. Immunology 2007, 122:466-475.
30. Tupin E., Kinjo Y., Kronenberg M. The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol 2007, 5:405-417.